You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
7 January 2024
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase
9 November 2022
Release of a capital market information
3 November 2022
Qiagen N.V.: Elizabeth E. Tallett, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent to …
Qiagen N.V.: Dr. Metin Colpan, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent to the …
2 November 2022
29
Apr 24
Press Release – quarterly financial report (call-date Q1)
17
Jun 24
Analysts’ Conference
11 March 2024
Annual financial report 2023
1 November 2023
Q3 statement / Q3 financial report 2023
10 August 2023
Half-yearly financial report 2023
5 May 2023
Q1 statement / Q1 financial report 2023
13 March 2023
Annual financial report 2022